Intravitreal Fluocinolone Acetonide Implant (ILUVIEN®) for the Treatment of Retinal Conditions. A Review of Clinical Studies [PDF]
Drug Design, Development and Therapy, 2023 Fluocinolone acetonide (FAc) intravitreal implant (Iluvien®) is a corticosteroid implant indicated for the treatment of diabetic macular oedema (DMO) in patients who have previously received conventional treatment without good response, non– infectious ...
Matteo Ripa +2 more
exaly +4 more sources
Anterior migration of intravitreal fluocinolone acetonide (Iluvien®) implant in a pseudophakic eye with intact posterior capsule [PDF]
American Journal of Ophthalmology Case Reports, 2020 Purpose: To describe a case of spontaneous anterior migration of intravitreal fluocinolone acetonide (Iluvien®) implant in a pseudophakic eye with intact posterior capsule.
Ahmed Mohammed Elbarky
exaly +4 more sources
Changes in Macular Perfusion After ILUVIEN® Intravitreal Implant for Diabetic Macular Edema: An OCTA Study [PDF]
Ophthalmology and Therapy, 2022 Maria Brambati +2 more
exaly +4 more sources
Visual function and retinal morphological changes after single suprachoroidal delivery of fluocinolone acetonide (Iluvien®) implant in eyes with chronic diabetic macular edema [PDF]
International Journal of Retina and Vitreous, 2023 Background To assess the efficacy and safety of supra-choroidal (SC) Iluvien in the management of chronic diabetic macular edema (DME). Methods A retrospective interventional non-comparative consecutive case series including patients with chronic DME who
Ehab N. El Rayes, Mahmoud Leila
doaj +2 more sources
Beyond Vision: Prospective Real-World Evaluation of Quality-of-Life and Caregiver Burden in Diabetic Macular Edema Treated with Fluocinolone Acetonide (Iluvien®) [PDF]
Ophthalmology and TherapyIntroduction Diabetic macular edema (DME) imposes a substantial clinical and psychosocial burden on patients and caregivers due to frequent visits and intravitreal treatments.
João Alves-Ambrósio +4 more
doaj +2 more sources
Intravitreal steroid implants in the management of noninfectious intermediate and posterior uveitis [PDF]
Indian Journal of OphthalmologyThe management of intermediate and posterior uveitis poses a significant challenge of achieving adequate drug concentrations in the posterior segment over the chronic nature of the disease.
Sarjak M Shah +2 more
doaj +2 more sources
Fluocinolone intravitreal implant (Iluvien) for macular edema secondary to immune recovery uveitis in patient with acute myeloid leukemia [PDF]
Journal of Ophthalmic Inflammation and InfectionPurpose To report the use of Fluocinolone intravitreal implant (Iluvien) for the treatment of persistent cystoid macular edema (CME) due to immune recovery uveitis syndrome in a patient with previous cytomegalovirus retinitis and acute myeloid leukemia ...
JM Cachero Rodríguez +3 more
doaj +2 more sources
Intravitreal Fluocinolone Acetonide (ILUVIEN) Implant for the Treatment of Refractory Cystoid Macular Oedema After Retinal Detachment Repair [PDF]
Türk Oftalmoloji Dergisi, 2018 Cystoid macular oedema (CMO) is one of the most frequent postoperative macular complications to cause partial visual recovery after successful retinal detachment (RD) repair.
Fadi Alfaqawi +4 more
doaj +3 more sources
Prevalence and Risk Factors of Ocular Hypertension Following Fluocinolone Acetonide (Iluvien®) Intravitreal Injections: The “SAFAC” Study [PDF]
Ophthalmology and TherapyIntroduction The aim of this real-life study was to analyze the prevalence and risk factors of ocular hypertension (OHT) after fluocinolone acetonide implant (FAc-I) intravitreal injections in the treatment of macular edema of various etiologies. Methods
Yasmine Serrar +9 more
doaj +2 more sources
Journal of International Medical Research, 2019 Diabetic macular oedema (DMO) is a common complication of diabetic retinopathy and may lead to severe visual loss. In this review, we describe the pathophysiology of DMO and review current therapeutic options such as macular laser photocoagulation, anti ...
Horace Massa +2 more
exaly +2 more sources